Citigroup’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,100
Closed -$432K 7476
2020
Q3
$432K Sell
1,100
-1,600
-59% -$592K ﹤0.01% 3978
2020
Q2
$891K Hold
2,700
﹤0.01% 3671
2020
Q1
$654K Sell
2,700
-1,300
-33% -$339K ﹤0.01% 3615
2019
Q4
$1.04M Sell
4,000
-3,700
-48% -$975K ﹤0.01% 3707
2019
Q3
$2.09M Buy
7,700
+3,000
+64% +$835K ﹤0.01% 2819
2019
Q2
$1.29M Buy
4,700
+1,700
+57% +$419K ﹤0.01% 3329
2019
Q1
$671K Sell
3,000
-2,400
-44% -$495K ﹤0.01% 3855
2018
Q4
$1M Buy
5,400
+3,100
+135% +$636K ﹤0.01% 3394
2018
Q3
$574K Sell
2,300
-2,200
-49% -$534K ﹤0.01% 4114
2018
Q2
$981K Buy
4,500
+2,500
+125% +$515K ﹤0.01% 3382
2018
Q1
$383K Sell
2,000
-3,600
-64% -$664K ﹤0.01% 4265
2017
Q4
$876K Buy
5,600
+3,200
+133% +$504K ﹤0.01% 3469
2017
Q3
$373K Buy
2,400
+1,200
+100% +$190K ﹤0.01% 4394
2017
Q2
$194K Sell
1,200
-500
-29% -$81.2K ﹤0.01% 4818
2017
Q1
$263K Sell
1,700
-9,900
-85% -$1.36M ﹤0.01% 4434
2016
Q4
$1.36M Buy
11,600
+11,100
+2,220% +$1.27M ﹤0.01% 3378
2016
Q3
$56K Buy
+500
New +$52.7K ﹤0.01% 5595

Other funds holding IDXX

Citigroup's IDXX Position: Q1 2026 in Review

Citigroup increased its Idexx Laboratories (IDXX) stake by 2.8% in Q1 2026, buying an estimated $2.1M and bringing the position to 120,283 shares worth $67.6M. The position accounts for 0.03% of the portfolio, ranked #535.

Citigroup first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $92.3M in Q3 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Citigroup held 120,283 shares of Idexx Laboratories worth $67.6M as of Q1 2026.
  • Citigroup bought 3,276 Idexx Laboratories shares in Q1 2026, an estimated $2.1M.
  • Idexx Laboratories made up 0.03% of Citigroup's portfolio in Q1 2026, its #535 holding.
  • Citigroup first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Idexx Laboratories position peaked at $92.3M in Q3 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.